nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP2E1—Thalidomide—leprosy	0.221	0.303	CbGbCtD
Rufinamide—CYP2E1—Rifampicin—leprosy	0.214	0.293	CbGbCtD
Rufinamide—CYP2E1—Dapsone—leprosy	0.176	0.242	CbGbCtD
Rufinamide—CYP3A4—Rifampicin—leprosy	0.0647	0.0888	CbGbCtD
Rufinamide—CYP3A4—Dapsone—leprosy	0.0534	0.0733	CbGbCtD
Rufinamide—SCN3A—spinal nerve—leprosy	0.0338	0.217	CbGeAlD
Rufinamide—SCN11A—peripheral nervous system—leprosy	0.0181	0.116	CbGeAlD
Rufinamide—SCN11A—nerve—leprosy	0.0141	0.0906	CbGeAlD
Rufinamide—SCN8A—peripheral nervous system—leprosy	0.0137	0.088	CbGeAlD
Rufinamide—Status epilepticus—Thalidomide—leprosy	0.0109	0.0946	CcSEcCtD
Rufinamide—SCN8A—nerve—leprosy	0.0107	0.0686	CbGeAlD
Rufinamide—SCN10A—peripheral nervous system—leprosy	0.00915	0.0589	CbGeAlD
Rufinamide—Enuresis—Thalidomide—leprosy	0.00902	0.078	CcSEcCtD
Rufinamide—SCN10A—nerve—leprosy	0.00714	0.0459	CbGeAlD
Rufinamide—GRM5—testis—leprosy	0.00434	0.028	CbGeAlD
Rufinamide—GRM5—nervous system—leprosy	0.00426	0.0274	CbGeAlD
Rufinamide—Nystagmus—Thalidomide—leprosy	0.00361	0.0312	CcSEcCtD
Rufinamide—Nasopharyngitis—Dapsone—leprosy	0.00327	0.0283	CcSEcCtD
Rufinamide—SCN11A—nervous system—leprosy	0.00317	0.0204	CbGeAlD
Rufinamide—Influenza—Dapsone—leprosy	0.00316	0.0273	CcSEcCtD
Rufinamide—Acne—Thalidomide—leprosy	0.00306	0.0265	CcSEcCtD
Rufinamide—Bone disorder—Thalidomide—leprosy	0.00285	0.0247	CcSEcCtD
Rufinamide—SCN7A—testis—leprosy	0.00274	0.0176	CbGeAlD
Rufinamide—Sinusitis—Dapsone—leprosy	0.00264	0.0229	CcSEcCtD
Rufinamide—Gait disturbance—Thalidomide—leprosy	0.00264	0.0228	CcSEcCtD
Rufinamide—Coordination abnormal—Thalidomide—leprosy	0.00262	0.0227	CcSEcCtD
Rufinamide—SCN9A—tendon—leprosy	0.00259	0.0167	CbGeAlD
Rufinamide—SCN8A—testis—leprosy	0.00244	0.0157	CbGeAlD
Rufinamide—SCN8A—nervous system—leprosy	0.0024	0.0154	CbGeAlD
Rufinamide—SCN4A—tendon—leprosy	0.00231	0.0149	CbGeAlD
Rufinamide—Lymphadenopathy—Thalidomide—leprosy	0.00219	0.019	CcSEcCtD
Rufinamide—SCN9A—testis—leprosy	0.00215	0.0138	CbGeAlD
Rufinamide—Vision blurred—Dapsone—leprosy	0.00207	0.0179	CcSEcCtD
Rufinamide—Increased appetite—Thalidomide—leprosy	0.00199	0.0172	CcSEcCtD
Rufinamide—Vertigo—Dapsone—leprosy	0.00198	0.0171	CcSEcCtD
Rufinamide—SCN4A—testis—leprosy	0.00192	0.0123	CbGeAlD
Rufinamide—SCN4A—nervous system—leprosy	0.00188	0.0121	CbGeAlD
Rufinamide—Diplopia—Thalidomide—leprosy	0.00187	0.0162	CcSEcCtD
Rufinamide—SCN1A—nervous system—leprosy	0.00181	0.0117	CbGeAlD
Rufinamide—SCN3A—tendon—leprosy	0.0018	0.0116	CbGeAlD
Rufinamide—Ataxia—Thalidomide—leprosy	0.00176	0.0152	CcSEcCtD
Rufinamide—CES1—testis—leprosy	0.00171	0.011	CbGeAlD
Rufinamide—Breast disorder—Thalidomide—leprosy	0.00169	0.0146	CcSEcCtD
Rufinamide—CES1—nervous system—leprosy	0.00168	0.0108	CbGeAlD
Rufinamide—SCN2A—nervous system—leprosy	0.00166	0.0107	CbGeAlD
Rufinamide—Insomnia—Dapsone—leprosy	0.00162	0.014	CcSEcCtD
Rufinamide—Influenza—Thalidomide—leprosy	0.00162	0.014	CcSEcCtD
Rufinamide—SCN10A—nervous system—leprosy	0.00161	0.0103	CbGeAlD
Rufinamide—Bronchitis—Thalidomide—leprosy	0.00155	0.0134	CcSEcCtD
Rufinamide—Neutropenia—Thalidomide—leprosy	0.00151	0.0131	CcSEcCtD
Rufinamide—Pollakiuria—Thalidomide—leprosy	0.00149	0.0129	CcSEcCtD
Rufinamide—SCN3A—testis—leprosy	0.00149	0.00959	CbGeAlD
Rufinamide—SCN3A—nervous system—leprosy	0.00146	0.00941	CbGeAlD
Rufinamide—Weight decreased—Thalidomide—leprosy	0.00146	0.0127	CcSEcCtD
Rufinamide—SCN5A—nervous system—leprosy	0.00146	0.00939	CbGeAlD
Rufinamide—Pneumonia—Thalidomide—leprosy	0.00145	0.0125	CcSEcCtD
Rufinamide—Infestation NOS—Thalidomide—leprosy	0.00144	0.0125	CcSEcCtD
Rufinamide—Infestation—Thalidomide—leprosy	0.00144	0.0125	CcSEcCtD
Rufinamide—Haematuria—Thalidomide—leprosy	0.00137	0.0119	CcSEcCtD
Rufinamide—Epistaxis—Thalidomide—leprosy	0.00136	0.0118	CcSEcCtD
Rufinamide—Sinusitis—Thalidomide—leprosy	0.00135	0.0117	CcSEcCtD
Rufinamide—Rhinitis—Thalidomide—leprosy	0.0013	0.0112	CcSEcCtD
Rufinamide—Urinary tract disorder—Thalidomide—leprosy	0.00128	0.0111	CcSEcCtD
Rufinamide—Urethral disorder—Thalidomide—leprosy	0.00127	0.011	CcSEcCtD
Rufinamide—Eye disorder—Thalidomide—leprosy	0.00121	0.0105	CcSEcCtD
Rufinamide—Cardiac disorder—Thalidomide—leprosy	0.0012	0.0104	CcSEcCtD
Rufinamide—ALB—testis—leprosy	0.00119	0.00766	CbGeAlD
Rufinamide—Immune system disorder—Thalidomide—leprosy	0.00117	0.0101	CcSEcCtD
Rufinamide—Mediastinal disorder—Thalidomide—leprosy	0.00117	0.0101	CcSEcCtD
Rufinamide—Vomiting—Dapsone—leprosy	0.00114	0.00988	CcSEcCtD
Rufinamide—Mental disorder—Thalidomide—leprosy	0.00113	0.00981	CcSEcCtD
Rufinamide—Malnutrition—Thalidomide—leprosy	0.00113	0.00974	CcSEcCtD
Rufinamide—Headache—Dapsone—leprosy	0.00113	0.00973	CcSEcCtD
Rufinamide—Back pain—Thalidomide—leprosy	0.00109	0.00942	CcSEcCtD
Rufinamide—Nausea—Dapsone—leprosy	0.00107	0.00923	CcSEcCtD
Rufinamide—Vision blurred—Thalidomide—leprosy	0.00106	0.00918	CcSEcCtD
Rufinamide—Tremor—Thalidomide—leprosy	0.00106	0.00913	CcSEcCtD
Rufinamide—Anaemia—Thalidomide—leprosy	0.00104	0.00901	CcSEcCtD
Rufinamide—Agitation—Thalidomide—leprosy	0.00104	0.00895	CcSEcCtD
Rufinamide—Vertigo—Thalidomide—leprosy	0.00101	0.00875	CcSEcCtD
Rufinamide—Leukopenia—Thalidomide—leprosy	0.00101	0.00872	CcSEcCtD
Rufinamide—Convulsion—Thalidomide—leprosy	0.000976	0.00844	CcSEcCtD
Rufinamide—Anxiety—Thalidomide—leprosy	0.000956	0.00827	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000952	0.00824	CcSEcCtD
Rufinamide—Infection—Thalidomide—leprosy	0.000913	0.0079	CcSEcCtD
Rufinamide—Nervous system disorder—Thalidomide—leprosy	0.000902	0.0078	CcSEcCtD
Rufinamide—Thrombocytopenia—Thalidomide—leprosy	0.0009	0.00779	CcSEcCtD
Rufinamide—Skin disorder—Thalidomide—leprosy	0.000893	0.00772	CcSEcCtD
Rufinamide—Anorexia—Thalidomide—leprosy	0.000876	0.00758	CcSEcCtD
Rufinamide—CYP2E1—tendon—leprosy	0.00085	0.00547	CbGeAlD
Rufinamide—Insomnia—Thalidomide—leprosy	0.000832	0.00719	CcSEcCtD
Rufinamide—Somnolence—Thalidomide—leprosy	0.000817	0.00707	CcSEcCtD
Rufinamide—Dyspepsia—Thalidomide—leprosy	0.000809	0.007	CcSEcCtD
Rufinamide—Decreased appetite—Thalidomide—leprosy	0.000799	0.00691	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Thalidomide—leprosy	0.000794	0.00687	CcSEcCtD
Rufinamide—Fatigue—Thalidomide—leprosy	0.000793	0.00686	CcSEcCtD
Rufinamide—Constipation—Thalidomide—leprosy	0.000786	0.0068	CcSEcCtD
Rufinamide—CYP2E1—testis—leprosy	0.000704	0.00453	CbGeAlD
Rufinamide—CYP2E1—nervous system—leprosy	0.000691	0.00444	CbGeAlD
Rufinamide—Hypersensitivity—Thalidomide—leprosy	0.000677	0.00586	CcSEcCtD
Rufinamide—Asthenia—Thalidomide—leprosy	0.00066	0.00571	CcSEcCtD
Rufinamide—Pruritus—Thalidomide—leprosy	0.00065	0.00563	CcSEcCtD
Rufinamide—Diarrhoea—Thalidomide—leprosy	0.000629	0.00544	CcSEcCtD
Rufinamide—Dizziness—Thalidomide—leprosy	0.000608	0.00526	CcSEcCtD
Rufinamide—Vomiting—Thalidomide—leprosy	0.000585	0.00506	CcSEcCtD
Rufinamide—Rash—Thalidomide—leprosy	0.00058	0.00501	CcSEcCtD
Rufinamide—Dermatitis—Thalidomide—leprosy	0.000579	0.00501	CcSEcCtD
Rufinamide—Headache—Thalidomide—leprosy	0.000576	0.00498	CcSEcCtD
Rufinamide—CYP3A4—nervous system—leprosy	0.000556	0.00358	CbGeAlD
Rufinamide—Nausea—Thalidomide—leprosy	0.000546	0.00472	CcSEcCtD
